The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-in-human study of PM14 in patients with advanced solid tumors.
 
Maria Vieito
No Relationships to Disclose
 
Santiago Ponce Aix
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Roche
Speakers' Bureau - Bristol-Myers Squibb; Merck; Roche
Travel, Accommodations, Expenses - AstraZeneca; Merck; Roche
 
Luis G. Paz-Ares
Leadership - ALTUM Sequencing; Genomica
Honoraria - Amgen; AstraZeneca; Bayer; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Ipsen; Lilly; Merck Serono; Mirati Therapeutics; Mirati Therapeutics; MSD; Novartis; Pfizer; PharmaMar; Roche/Genentech; Sanofi; Servier; Takeda
Speakers' Bureau - AstraZeneca; BMS; Lilly; Merck Serono; MSD Oncology; Pfizer; Roche/Genentech
Research Funding - AstraZeneca (Inst); BMS (Inst); Kura Oncology (Inst); MSD (Inst); PharmaMar (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; MSD; Pfizer; Roche; Takeda
Other Relationship - Amgen (I); Ipsen (I); Merck (I); Novartis (I); Pfizer (I); Roche; Roche (I); Sanofi (I); SERVIER (I)
 
Rastilav Bahleda
No Relationships to Disclose
 
Christophe Massard
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; BeiGene; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Debiopharm Group; Genentech/Roche; Innate Pharma; Ipsen; Janssen; Lilly; MSD; Novartis; Orion; Pfizer; PharmaMar; Sanofi; Taiho Pharmaceutical
 
Leyre Agreda
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Eva Banus
No Relationships to Disclose
 
Cristian Marcelo Fernandez
Employment - PharmaMar
 
Elena Y Cristoveanu
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Gema Corral
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Lourdes Llanero
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Rubin Lubomirov
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Carmen Maria Kahatt
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Salvador Fudio
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Antonio Nieto
Employment - PharmaMar
Stock and Other Ownership Interests - PharmaMar
 
Martin Cullell-Young
Employment - PharmaMar
 
Ali Hassan Zeaiter
Employment - PharmaMar
Leadership - PharmaMar
Stock and Other Ownership Interests - PharmaMar; SERVIER
Honoraria - PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Honey Kumar Oberoi
No Relationships to Disclose
 
Elena Garralda
Consulting or Advisory Role - Alkermes; Anaveon; Boehringer Ingelheim; Bristol-Myers Squibb; Ellipses Pharma; Janssen; MAB Discovery; NeoMed; Roche; Seagen; TFS; Thermo Fisher Scientific
Speakers' Bureau - Lilly; MSD; Roche; Thermo Fisher Scientific
Research Funding - AstraZeneca/MedImmune; Novartis; Roche (Inst); Taiho Oncology (Inst); Thermo Fisher Scientific (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Glycotope GmbH; Menarini; Merck Sharp & Dohme